{"name":"Joanne Kurtzberg, MD","slug":"joanne-kurtzberg-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"ALDHbr Umbilical Cord Blood Cells","genericName":"ALDHbr Umbilical Cord Blood Cells","slug":"aldhbr-umbilical-cord-blood-cells","indication":"Other","status":"phase_1"},{"name":"Autologous UCB Reinfusion","genericName":"Autologous UCB Reinfusion","slug":"autologous-ucb-reinfusion","indication":"Cerebral palsy (Phase 2)","status":"phase_2"},{"name":"CliniMACS CD34 Reagent System","genericName":"CliniMACS CD34 Reagent System","slug":"clinimacs-cd34-reagent-system","indication":"Other","status":"phase_2"},{"name":"Cord Tissue Mesenchymal Stromal Cells","genericName":"Cord Tissue Mesenchymal Stromal Cells","slug":"cord-tissue-mesenchymal-stromal-cells","indication":"Treatment of cerebral palsy","status":"phase_2"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Cord Blood Infusion","genericName":"Cord Blood Infusion","slug":"cord-blood-infusion","indication":"Treatment of severe combined immunodeficiency (SCID)","status":"phase_2"}]}],"pipeline":[{"name":"ALDHbr Umbilical Cord Blood Cells","genericName":"ALDHbr Umbilical Cord Blood Cells","slug":"aldhbr-umbilical-cord-blood-cells","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Autologous UCB Reinfusion","genericName":"Autologous UCB Reinfusion","slug":"autologous-ucb-reinfusion","phase":"phase_2","mechanism":"Autologous umbilical cord blood (UCB) cells are reinfused into patients to promote immune reconstitution and tissue repair.","indications":["Cerebral palsy (Phase 2)","Autism spectrum disorder (Phase 2)"],"catalyst":""},{"name":"CliniMACS CD34 Reagent System","genericName":"CliniMACS CD34 Reagent System","slug":"clinimacs-cd34-reagent-system","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"Cord Blood Infusion","genericName":"Cord Blood Infusion","slug":"cord-blood-infusion","phase":"phase_2","mechanism":"Cord blood infusion involves the transfer of hematopoietic stem cells from the umbilical cord to a recipient to stimulate the production of new blood cells.","indications":["Treatment of severe combined immunodeficiency (SCID)","Treatment of leukemia and lymphoma","Treatment of other blood-related disorders"],"catalyst":""},{"name":"Cord Tissue Mesenchymal Stromal Cells","genericName":"Cord Tissue Mesenchymal Stromal Cells","slug":"cord-tissue-mesenchymal-stromal-cells","phase":"phase_2","mechanism":"Cord Tissue Mesenchymal Stromal Cells are thought to exert therapeutic effects through immunomodulation and tissue repair.","indications":["Treatment of cerebral palsy"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQUVhkQVlIWm5kdU1mN3pfcVFnbzA1ODhBSEd5Q2phWF95bDluQWZjbEhtRDRSTWFvbU81ZHNCTVlGZkQwM1Y0UXBkUGVNRHZpT053VllKS0YzejEyVEJZbmpTckxjZnNGcDJJUUlhdl9PS3dTeFRXN2VJVlRfODNsYVcyVVVjQktEQXo1UlNVeUw2WnpsajhBYm9aa3A?oc=5","date":"2024-12-19","type":"regulatory","source":"Fierce Pharma","summary":"After two rejections, FDA approves Mesoblast's first-of-its-kind cell therapy - Fierce Pharma","headline":"After two rejections, FDA approves Mesoblast's first-of-its-kind cell therapy","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNNWZYWU4tclV5Vm5DR0h0alczaFJZMXNIc0lwM0FQelIxNWJmdzdTUmoyWGd5cjFYWHA5TnkzZDlDWkgwN2xrMFFGQXEybDBhY0dHY1hPZ0NBU2hkT2twSHIwYjc5LVUxNi1ZbU51UWZZMkVFNTBoWEVjU0ZKeEtzcFVYakN0cmFIQUFHamFyTVRFOGFjaDJOMk4wYUU5cU1wYU5uS2N6VldRb2dfVGxKanBBZjA5QTBzNTNVSFEzZGZvamNtYzY0ZmZYeGs?oc=5","date":"2023-03-02","type":"pipeline","source":"BioPharma APAC","summary":"12 Leading Women Who Transformed Cell & Gene Therapy: A Tribute on International Women's Day - BioPharma APAC","headline":"12 Leading Women Who Transformed Cell & Gene Therapy: A Tribute on International Women's Day","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_1":1,"phase_2":4},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}